ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.01%
Brent Oil
76.495
0.00%
Bitcoin
97,637.75
-0.48%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Neuraxis Inc (NRXS)

  7. Neuraxis Inc (NRXS) Noticias

NRXS

Neuraxis (NRXS)

Neuraxis Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:NRXS
FechaHoraFuenteTítuloSímboloCompañía
13/12/202415:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:NRXSNeuraxis Inc
10/12/202408:00GlobeNewswire Inc.NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic ConstipationAMEX:NRXSNeuraxis Inc
25/11/202415:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NRXSNeuraxis Inc
12/11/202407:10GlobeNewswire Inc.NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in RevenuesAMEX:NRXSNeuraxis Inc
05/11/202408:00GlobeNewswire Inc.NeurAxis to Host Third Quarter 2024 Results and Business Update Call on Tuesday, November 12, 2024AMEX:NRXSNeuraxis Inc
04/11/202408:00GlobeNewswire Inc.NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable MarketAMEX:NRXSNeuraxis Inc
29/10/202408:00GlobeNewswire Inc.NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024AMEX:NRXSNeuraxis Inc
22/10/202408:00GlobeNewswire Inc.NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field StimulationAMEX:NRXSNeuraxis Inc
19/09/202408:00GlobeNewswire Inc.NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024AMEX:NRXSNeuraxis Inc
27/08/202408:00GlobeNewswire Inc.NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024AMEX:NRXSNeuraxis Inc
13/08/202408:00GlobeNewswire Inc.NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024AMEX:NRXSNeuraxis Inc
09/08/202407:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NRXSNeuraxis Inc
09/08/202407:00GlobeNewswire Inc.NeurAxis Reports Second Quarter 2024 Financial ResultsAMEX:NRXSNeuraxis Inc
05/08/202408:00GlobeNewswire Inc.NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024AMEX:NRXSNeuraxis Inc
07/06/202408:00GlobeNewswire Inc.NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit DisclosureAMEX:NRXSNeuraxis Inc
22/05/202407:00GlobeNewswire Inc.NeurAxis Reports First Quarter 2024 Financial ResultsAMEX:NRXSNeuraxis Inc
21/05/202408:00GlobeNewswire Inc.NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024AMEX:NRXSNeuraxis Inc
16/05/202408:00GlobeNewswire Inc.NeurAxis Announces New Medical Policy Coverage For Nearly Six Million Lives in FloridaAMEX:NRXSNeuraxis Inc
15/05/202415:30GlobeNewswire Inc.NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024AMEX:NRXSNeuraxis Inc
15/05/202415:15Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBAMEX:NRXSNeuraxis Inc
23/04/202408:00GlobeNewswire Inc.NeurAxis Announces New Medical Policy Coverage in North DakotaAMEX:NRXSNeuraxis Inc
09/04/202415:05GlobeNewswire Inc.NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsAMEX:NRXSNeuraxis Inc
01/04/202415:15GlobeNewswire Inc.NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024AMEX:NRXSNeuraxis Inc
27/03/202408:00GlobeNewswire Inc.NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center RegistryAMEX:NRXSNeuraxis Inc
11/03/202408:00GlobeNewswire Inc.NeurAxis Announces Highmark BCBS Policy CoverageAMEX:NRXSNeuraxis Inc
04/03/202408:00GlobeNewswire Inc.NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy CoverageAMEX:NRXSNeuraxis Inc
27/02/202410:00GlobeNewswire Inc.NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceAMEX:NRXSNeuraxis Inc
20/12/202308:00GlobeNewswire Inc.NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerAMEX:NRXSNeuraxis Inc
19/12/202316:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:NRXSNeuraxis Inc
20/11/202316:30GlobeNewswire Inc.NeurAxis Reports Third Quarter 2023 Financial ResultsAMEX:NRXSNeuraxis Inc
 Showing the most relevant articles for your search:AMEX:NRXS

Su Consulta Reciente

BIT
UB8VQR
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados